BUZZ-Invivyd因制药商启动COVID预防抗体后期试验而上涨

路透中文
Dec 23, 2025
BUZZ-Invivyd因制药商启动COVID预防抗体后期试验而上涨

12月23日 - ** 制药商Invivyd IVVD.O股价盘前上涨1.4%至2.92美元

** 该公司称已开始晚期临床试验,测试其试验性新冠抗体VYD2311作为该疾病的预防性治疗药物的效果

** 该公司表示,该研究将招募 1770 名成人和青少年;比较单次注射与每月注射安慰剂的效果

** IVVD 公司称,其目标是为寻求保护的高危人群提供疫苗替代品

** 预计将在 2026 年中期取得初步结果 - IVVD

** 截至上次收盘,股价年累计上涨约 133

(为便利非英文母语者,路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误,或未能包含所需语境,路透不保证自动化翻译文本的准确性,仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失,路透不承担任何责任。)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10